[1] Wang T, Wang D, Dong D.Thinking on the construction of China's pharmacovigilance system[J].China Food and Drug Administration(中国食品药品监管), 2019(1):37-41. [2] Feng YN, Liu XX, Li YH, et al.Challenges faced by medical institutions' pharmacovigilance work under the new "Drug Administration Law"[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(9): 572-573, 582. [3] Song CY, Wang XN, Xin L.Innovative drug supervision methods to create a new pattern of smart supervision[J]. China Food and Drug Administration(中国食品药品监管), 2020(3): 54-59. [4] Yuan L, Gao Y, Lu CF.Preliminary thinking on establishing a pharmacovigilance system in my country[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(11): 749-752. [5] Zhang J, Fu W, Wang JK.The status and role of medical institutions in pharmacovigilance[J]. China Pharmacy(中国药房), 2009, 20(2): 81-83. [6] Su YK.Discussion on my country's pharmacovigilance system[J]. Tianjin Pharmacy(天津药学), 2013, 25(1): 61-63. [7] Shen Q, Zhang L, Yan SY, et al.The role of pharmacovigilance system in the safe use of drugs in medical institutions[J]. China Pharmacy(中国药房), 2012, 23(10): 865-867. [8] Wu GS.The main problems and countermeasures of adverse drug reaction monitoring in our hospital[J].China Pharmacy(中国药房), 2007(8): 619-620. [9] Peng LL, Fan Y, Liu W, et al.Discuss how pharmaceutical manufacturers establish a pharmacovigilance system[J]. Chinese Pharmacovigilance(中国药物警戒), 2017, 14(11): 666-670. [10] Ma S.Analysis and countermeasures of problems in quality management of traditional Chinese medicine decoction pieces in hospital Chinese pharmacies[J]. Electronic Journal of Integrated Traditional Chinese and Western Medicine in Cardiovascular Diseases(中西医结合心血管病电子杂志), 2020, 8(35): 190-191. [11] Huang X.Research on the storage and maintenance of chinese herbal pieces[J]. Asia-Pacific Traditional Medicine(亚太传统医药), 2013, 9(11): 202-203. [12] Zeng FD.Pharmacovigilance and clinical pharmacy services[J]. Journal of Pharmacoepidemiology(药物流行病学杂志), 2014, 23(12): 718-721. [13] Wu JY, Zhang M, Wang RL, et al. Constructing the knowledge system of surgical pharmacists-surgical pharmacy [J/OL]. Pharmacy Today(今日药学): (2020-12-01) [2020-12-04]. http://kns.cnki.net/ kcms/detail/44.1650.R.20201201.1013.002.html. [14] Lin ZJ, Zhang B.Introduction to the practice training model of Mayo clinical pharmacists and its enlightenment to the training of clinical Chinese pharmacists in my country[J]. Education of Chinese Medicine(中医教育), 2019, 38(4): 31-34. [15] Shi CX, Tian MD, Shi JJ, et al.Types and causes analysis of unreasonable prescriptions of traditional Chinese medicine in a hospital[J]. Chinese Medical Guide(中国医药指南), 2020, 18(10): 168-169, 172. [16] Zhou MH, Wu XL, Zhang JF.A comparative study of clinical pharmacists participating in the formulation and implementation of orthopedic TCM clinical pathways[J]. Chinese Pharmacist(中国药师), 2017, 20(12): 2180-2182,2189. [17] Xing J.Research on the effect of traditional Chinese medicine and pharmaceutical services in reducing adverse reactions of traditional Chinese medicine[J]. Psychological Monthly(心理月刊), 2018(4): 44-45. [18] Gao J.The professional status of clinical pharmacists in pharmaco-vigilance[J]. China Pharmaceuticals(中国药业), 2016, 25(19): 77-79. [19] Xie YM.Evidence-based research and practice on the safety of traditional Chinese medicine(循证中医药安全性证据研究与实践) [M]. Beijing: People's Medical Publishing House, 2019: 190. [20] Tao QM, Zhan SY.Application of prescription sequence analysis and prescription sequence symmetry analysis in pharmacoe-pidemiology[J]. Journal of Pharmacoepidemiology(药物流行病学杂志), 2012, 21(10): 517-519. [21] Zhou YF, Cheng YC, Gao SQ, et al.Taking Xiyanping injection as an example to explore the ability of prescription sequence symmetry analysis to detect allergic signals[J]. Journal of Pharmaceutical Epidemiology(药物流行病学杂志), 2019, 28(6): 376-379, 388. [22] Li N.The status quo and prospect of modern traditional Chinese medicine pharmacokinetics research and therapeutic drug monitoring based on "syndrome, medicine and effect"[J]. Chinese Pharmacist(中国药师), 2015, 18(7): 1140-1144. [23] Liu CX.Practical pharmacokinetics(实用药物动力学)[M].Beijing: China Medical Science and Technology Press, 2003: 274. [24] Wang YH, Chen TC, Pan HB.Drawing on the experience of western medicine clinical pharmacy to develop traditional Chinese medicine clinical pharmacy[J]. Chinese Pharmaceutical Affairs(中国药事), 1997, 11(4): 269. [25] Xu HX.Toxicity and prevention of Chinese medicine Maqianzi[J].Information on Traditional Chinese Medicine(中医药信息), 2005, 5: 87. [26] Shen YJ.Pharmacology of traditional Chinese medicine(中药药理学)[M]. Shanghai: Shanghai Science and Technology Press, 1997: 32, 189. [27] Li DX.Analysis of the causes of adverse reactions of traditional Chinese medicine[J]. Lishizhen Medicine and Materia Medica Research(时珍国医国药), 2004, 15(11): 803. [28] Xu JY.The main causes and countermeasures of adverse reactions of traditional Chinese medicine[J]. Chinese Medicine and Materia Medica(中医中药), 2006, 3(11) :121. [29] Feng YF, Liu PL, Li QH.The current situation and prospects of the monitoring of traditional Chinese medicine therapy[J]. Lishizhen Medicine and Materia Medica(时珍国医国药), 2007(5): 1255-1256. |